Leadership Overview
Bliss GVS Pharma has 5 executives leading key functions including financial strategy, global marketing, production coordination, market expansion, and brand management.
Committed to enhancing global well-being through accessible healthcare, Bliss GVS Pharma drives innovation in pharmaceutical manufacturing to deliver high-quality suppositories, pessaries, and essential medications to international markets.
Committed to enhancing global well-being through accessible healthcare, Bliss GVS Pharma drives innovation in pharmaceutical manufacturing to deliver high-quality suppositories, pessaries, and essential medications to international markets.
Leadership Roles at Bliss GVS Pharma
Deepak Sawant - Chief Financial Officer
Deepak Sawant, the Chief Financial Officer at Bliss GVS Pharma, directs all fiscal operations and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures rigorous compliance with international accounting standards while supporting the manufacturing of capsules, creams, and injections. This leadership role involves managing investor relations and optimizing the cost structure across global facilities to maintain the competitive edge of the company. By analyzing market trends and revenue streams, Deepak Sawant directly impacts the long-term growth trajectory of the firm. Furthermore, the Chief Financial Officer coordinates with the board to secure funding for infrastructure upgrades, ensuring that the production of suppositories and pessaries remains efficient. Through disciplined fiscal oversight, the Chief Financial Officer stabilizes the balance sheet, enabling the company to expand its reach into emerging healthcare markets across the globe.
Vijay Dalavi - Executive Chief Marketing Officer & Production Coordinator
Vijay Dalavi, the Executive Chief Marketing Officer & Production Coordinator at Bliss GVS Pharma, manages the intersection of market demand and manufacturing output. Overseeing the alignment of production schedules with global sales targets, the Executive Chief Marketing Officer & Production Coordinator ensures that the supply chain meets the needs of healthcare providers worldwide. This role involves streamlining the manufacturing of specialized pharmaceutical products to maximize efficiency and quality control. By bridging the gap between factory operations and consumer requirements, Vijay Dalavi directly influences the availability of essential healthcare items. The Executive Chief Marketing Officer & Production Coordinator also monitors regional market performance to adjust production volumes dynamically. Through this integrated approach, the Executive Chief Marketing Officer & Production Coordinator supports the mission of increasing pharmaceutical accessibility, ensuring that the company maintains its status as a leading manufacturer of suppositories and pessaries.
Sampat Jondhale - Manager Chief Marketing Officer
Sampat Jondhale, the Manager Chief Marketing Officer at Bliss GVS Pharma, architects the strategic outreach programs for the company's diverse pharmaceutical portfolio. Overseeing the promotion of capsules and creams, the Manager Chief Marketing Officer drives brand awareness among healthcare providers in key international territories. This leadership role involves analyzing regional market data to tailor messaging that highlights the efficacy of the company's healthcare solutions. By fostering strong relationships with distributors, Sampat Jondhale ensures that the products reach consumers effectively. The Manager Chief Marketing Officer also collaborates with the research teams to communicate the benefits of new pharmaceutical discoveries. Through targeted campaigns, the Manager Chief Marketing Officer expands the market presence of the firm, ensuring that the unique manufacturing capabilities of the company remain at the forefront of the industry. This focus on market penetration supports the broader goal of enhancing global well-being.
Aditi More - Senior Executive, Chief Marketing Officer
Aditi More, the Senior Executive, Chief Marketing Officer at Bliss GVS Pharma, leads the development of high-level marketing strategies for the company's specialized injection and suppository lines. Overseeing the positioning of these products within the global pharmaceutical landscape, the Senior Executive, Chief Marketing Officer ensures that the brand remains synonymous with quality and reliability. This role involves identifying new growth opportunities in emerging markets and crafting initiatives that increase product accessibility for diverse patient populations. By leveraging market intelligence, Aditi More directly influences the commercial success of the organization. The Senior Executive, Chief Marketing Officer also coordinates with cross-functional teams to ensure that marketing efforts align with the overall mission of rediscovering pharmaceutics. Through strategic planning and execution, the Senior Executive, Chief Marketing Officer strengthens the market impact of the company, ensuring that healthcare providers have consistent access to effective and affordable pharmaceutical solutions.
Vidula Ranade - Executive- Chief Marketing Officer
Vidula Ranade, the Executive- Chief Marketing Officer at Bliss GVS Pharma, manages the digital and traditional marketing channels for the company's extensive range of healthcare items. Overseeing the communication of product value to international healthcare providers, the Executive- Chief Marketing Officer ensures that the unique benefits of the company's manufacturing processes are clearly articulated. This role involves developing educational content that supports the adoption of new pharmaceutical solutions in various regions. By optimizing the marketing funnel, Vidula Ranade directly contributes to the expansion of the company's customer base. The Executive- Chief Marketing Officer also monitors competitive activity to refine the firm's market approach. Through consistent engagement with stakeholders, the Executive- Chief Marketing Officer drives the visibility of the company's world-class facilities. This leadership role is essential for maintaining the company's reputation as a trusted provider of high-quality pharmaceuticals, ultimately supporting the mission of enhancing global health outcomes.
Explore Leadership Teams in Manufacturing
Boehringer Ingelheim is a privately held, research-driven pharmaceutical company headquartered in Ingelheim am Rhein, Germany, founded in 1885. The company researches, develops, and manufactures prescription medicines and healthcare products across three core business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Its primary therapeutic focus areas include respiratory diseases, oncology, immunology, cardiometabolic conditions, and central nervous system disorders. Boehringer Ingelheim also develops and manufactures veterinary products for companion animals, livestock, and poultry. Operating in over 100 countries with more than 53,000 employees globally, the company maintains a broad network of research, manufacturing, and commercial sites across Europe, North America, and Asia. It is one of the largest privately owned pharmaceutical companies in the world.
Company Leadership JB

JM
SY
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia.
Company Leadership

AB
OneSource Specialty Pharma Limited is a multimodal specialty pharmaceutical contract development and manufacturing organization headquartered in Bengaluru, India. Formed through the merger of three CDMO businesses within the Strides Group, specifically Stelis Biopharma's Biologics CDMO, SteriScience's Complex Injectables, and Strides' Soft Gelatin businesses, OneSource was officially launched at CPHI Milan in 2024. The company operates five state-of-the-art manufacturing facilities in Bengaluru, all approved by major regulatory bodies including the US FDA, European Union authorities, and the Therapeutic Goods Administration. With over 30 years of manufacturing and quality excellence, OneSource employs more than 1,200 professionals, including over 200 techno-commercial experts, and serves more than 50 global pharmaceutical and biotechnology clients. The company specializes in end-to-end capabilities across multiple technology platforms and therapeutic modalities, including biologics drug substance and drug product manufacturing, drug-device combinations such as prefilled syringes and autoinjectors, complex sterile injectables, and soft gelatin capsules. OneSource has the capacity to produce over 100 million injectable doses and 2.4 billion soft gelatin capsules annually, with its flagship Bangalore site being one of the few facilities globally capable of manufacturing both biologics drug substance and drug product on the same premises. The company holds 35 approved Abbreviated New Drug Applications and has 19 commercialized drug products in the United States. Led by CEO Neeraj Sharma and Chief Quality Officer Bernhard Thurnbauer, OneSource is positioned to capitalize on growing demand for GLP-1 drug-device combinations and supply chain diversification driven by the BIOSECURE Act, projecting 32 percent revenue growth in 2025 with sales expected to reach 400 million dollars by 2028.
Company Leadership NS
SN
BM

Founded in 1997 and headquartered in West Columbia, South Carolina, Nephron Pharmaceuticals manufactures generic respiratory medications.
Company Leadership MW
AG
PK